BPrinStratTTE
From MaRDI portal
Software:5978738
CRANBPrinStratTTEMaRDI QIDQ5978738
Causal Effects in Principal Strata Defined by Antidrug Antibodies
Last update: 20 December 2023
Software version identifier: 0.0.2
Copyright license: GNU General Public License
Bayesian models to estimate causal effects of biological treatments on time-to-event endpoints in clinical trials with principal strata defined by the occurrence of antidrug antibodies. The methodology is based on Frangakis and Rubin (2002) <doi:10.1111/j.0006-341x.2002.00021.x> and Imbens and Rubin (1997) <doi:10.1214/aos/1034276631>, and intended to be applied to a specific time-to-event setting.